Search All UT System Experts

Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non- small cell lung cancer in vitro and in vivo

Jieru Meng, Bingbing Dai, Bingliang Fang, B. Nebiyou Bekele, William G. Bornmann, Duoli Sun, Zhenghong Peng, Roy S. Herbst, Vassiliki Papadimitrakopoulou, John D. Minna, Michael Peyton, Jack A. Roth

Research output: Contribution to journal › Article › peer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non- small cell lung cancer in vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences